Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, Oxfordshire, UK.
eThekwini Municipality Health Unit, eThekwini Municipality, Durban KwaZulu-Natal, South Africa.
Lancet HIV. 2021 Mar;8(3):e158-e165. doi: 10.1016/S2352-3018(20)30359-3. Epub 2021 Feb 4.
The effect of the COVID-19 pandemic on HIV outcomes in low-income and middle-income countries is poorly described. We aimed to measure the impact of the 2020 national COVID-19 lockdown on HIV testing and treatment in KwaZulu-Natal, South Africa, where 1·7 million people are living with HIV.
In this interrupted time series analysis, we analysed anonymised programmatic data from 65 primary care clinics in KwaZulu-Natal province, South Africa. We included data from people testing for HIV, initiating antiretroviral therapy (ART), and collecting ART at participating clinics during the study period, with no age restrictions. We used descriptive statistics to summarise demographic and clinical data, and present crude summaries of the main outcomes of numbers of HIV tests per month, ART initiations per week, and ART collection visits per week, before and after the national lockdown that began on March 27, 2020. We used Poisson segmented regression models to estimate the immediate impact of the lockdown on these outcomes, as well as post-lockdown trends.
Between Jan 1, 2018, and July 31, 2020, we recorded 1 315 439 HIV tests. Between Jan 1, 2018, and June 15, 2020, we recorded 71 142 ART initiations and 2 319 992 ART collection visits. We recorded a median of 41 926 HIV tests per month before lockdown (January, 2018, to March, 2020; IQR 37 838-51 069) and a median of 38 911 HIV tests per month after lockdown (April, 2020, to July, 2020; IQR 32 699-42 756). In the Poisson regression model, taking into account long-term trends, lockdown was associated with an estimated 47·6% decrease in HIV testing in April, 2020 (incidence rate ratio [IRR] 0·524, 95% CI 0·446-0·615). ART initiations decreased from a median of 571 per week before lockdown (IQR 498-678), to 375 per week after lockdown (331-399), with an estimated 46·2% decrease in the Poisson regression model in the first week of lockdown (March 30, 2020, to April 5, 2020; IRR 0·538, 0·459-0·630). There was no marked change in the number of ART collection visits (median 18 519 visits per week before lockdown [IQR 17 074-19 922] vs 17 863 visits per week after lockdown [17 509-18 995]; estimated effect in the first week of lockdown IRR 0·932, 95% CI 0·794-1·093). As restrictions eased, HIV testing and ART initiations gradually improved towards pre-lockdown levels (slope change 1·183/month, 95% CI 1·113-1·256 for HIV testing; 1·156/month, 1·085-1·230 for ART initiations).
ART provision was generally maintained during the 2020 COVID-19 lockdown, but HIV testing and ART initiations were heavily impacted. Strategies to increase testing and treatment initiation should be implemented.
Wellcome Trust, Africa Oxford Initiative.
COVID-19 大流行对中低收入国家的 HIV 结局的影响描述甚少。我们旨在衡量 2020 年南非夸祖鲁-纳塔尔省全国 COVID-19 封锁对 HIV 检测和治疗的影响,该省有 170 万人感染 HIV。
在这项中断时间序列分析中,我们分析了南非夸祖鲁-纳塔尔省 65 个初级保健诊所的匿名项目数据。我们纳入了在研究期间在参与诊所接受 HIV 检测、开始抗逆转录病毒治疗(ART)和收集 ART 的人群的数据,无年龄限制。我们使用描述性统计来总结人口统计学和临床数据,并在国家封锁(2020 年 3 月 27 日开始)前后,对 HIV 检测次数、ART 开始次数和 ART 收集就诊次数这三个主要结局的每月数量进行粗略总结。我们使用泊松分段回归模型来估计封锁对这些结局的直接影响,以及封锁后的趋势。
在 2018 年 1 月 1 日至 2020 年 7 月 31 日期间,我们记录了 1315439 次 HIV 检测。在 2018 年 1 月 1 日至 2020 年 6 月 15 日期间,我们记录了 71142 次 ART 开始和 2319992 次 ART 收集就诊。封锁前,我们每月记录中位数为 41926 次 HIV 检测(2018 年 1 月至 2020 年 3 月;IQR 37838-51069),封锁后每月记录中位数为 38911 次 HIV 检测(2020 年 4 月至 7 月;IQR 32699-42756)。在泊松回归模型中,考虑到长期趋势,封锁与 2020 年 4 月 HIV 检测估计下降 47.6%有关(发病率比[IRR]0.524,95%CI 0.446-0.615)。ART 开始从封锁前每周中位数 571 次(IQR 498-678)下降至每周 375 次(331-399),在封锁的第一周,泊松回归模型估计下降 46.2%(2020 年 3 月 30 日至 4 月 5 日;IRR 0.538,0.459-0.630)。ART 收集就诊次数没有明显变化(封锁前每周中位数为 18519 次(IQR 17074-19922),封锁后每周中位数为 17863 次(17509-18995);封锁第一周的估计效应 IRR 0.932,95%CI 0.794-1.093)。随着限制的放宽,HIV 检测和 ART 开始逐渐恢复到封锁前的水平(HIV 检测斜率变化为 1.183/月,95%CI 1.113-1.256;ART 开始斜率变化为 1.156/月,95%CI 1.085-1.230)。
在 2020 年 COVID-19 封锁期间,ART 供应总体上得以维持,但 HIV 检测和 ART 开始受到严重影响。应实施增加检测和治疗开始的策略。
惠康信托基金会、非洲牛津倡议。